Comparison of Glucose-Lowering Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis

Background: Multiple glucose-lowering drugs are available as add-ons to metformin for a second-line treatment for type 2 diabetes. However, no systematic and comparative data are available for them in China. We aimed to compare the effects of glucose-lowering drugs added to metformin in China. Metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Shuyan, Hu, Xiaoqian, Zhen, Xuemei, Shi, Lizheng, Shao, Hui, Sun, Xueshan, Gu, Yuxuan, Huang, Minzhuo, Dong, Hengjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504435/
https://www.ncbi.nlm.nih.gov/pubmed/36143082
http://dx.doi.org/10.3390/jcm11185435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9504435/
https://www.ncbi.nlm.nih.gov/pubmed/36143082
http://dx.doi.org/10.3390/jcm11185435

Ejemplares similares